PERSPECTIVE: Tepotinib plus cetuximab in patients with RAS/BRAF wild-type left-sided metastatic colorectal cancer and acquired resistance to anti-EGFR antibody therapy due to MET amplification

Simple item page
dc.conference.dateJUN 30-JUL 03, 2021
dc.conference.title23rd ESMO World Congress on Gastrointestinal Cance
dc.contributor.authorTabernero, J.
dc.contributor.authorBekaii-Saab, T.
dc.contributor.authorAguilera, M. Safont
dc.contributor.authorCubillo, A.
dc.contributor.authorGarcia-Carbonero, R.
dc.contributor.authorLimon, L.
dc.contributor.authorRodriguez-Salas, N.
dc.contributor.authorTournigand, C.
dc.contributor.authorBorg, C.
dc.contributor.authorRaghav, K.
dc.contributor.authorFinley, G.
dc.contributor.authorStrickler, J.
dc.contributor.authorBeier, F.
dc.contributor.authorSalim, S.
dc.contributor.authorEsser, R.
dc.contributor.authorLiu, E.
dc.contributor.authorAdrian, S.
dc.contributor.authorLopez-Lopez, C.
dc.contributor.authoraffiliation[Tabernero, J.] Vall dHebron Univ Hosp, Barcelona, Spain
dc.contributor.authoraffiliation[Tabernero, J.] Vall dHebron Inst Oncol, Barcelona, Spain
dc.contributor.authoraffiliation[Bekaii-Saab, T.] Mayo Clin Phoenix, Phoenix, AZ USA
dc.contributor.authoraffiliation[Aguilera, M. Safont] Univ Valencia, Gen Univ Hosp, Dept Med Oncol, Ciberonc, Valencia, Spain
dc.contributor.authoraffiliation[Cubillo, A.] HM Univ Sanchinarro Ctr Integral Oncol Clara Camp, Madrid, Spain
dc.contributor.authoraffiliation[Garcia-Carbonero, R.] UCM, Hosp Univ Octubre 12, CNIO, Imas12, Madrid, Spain
dc.contributor.authoraffiliation[Limon, L.] Hosp Univ Virgen del Rocio, Dept Med Oncol, Seville, Spain
dc.contributor.authoraffiliation[Rodriguez-Salas, N.] Hosp Univ La Paz, Madrid, Spain
dc.contributor.authoraffiliation[Tournigand, C.] Hop Henri Mondor, APHP, UPEC, Creteil, France
dc.contributor.authoraffiliation[Borg, C.] Univ Hosp Besancon, Dept Med Oncol, Besancon, France
dc.contributor.authoraffiliation[Raghav, K.] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA
dc.contributor.authoraffiliation[Finley, G.] Allegheny Hlth Network Canc Inst, Pittsburgh, PA USA
dc.contributor.authoraffiliation[Strickler, J.] Duke Univ, Med Ctr, Dept Med, Div Med Oncol, Durham, NC 27710 USA
dc.contributor.authoraffiliation[Beier, F.] Merck KGaA, Darmstadt, Germany
dc.contributor.authoraffiliation[Salim, S.] Merck KGaA, Darmstadt, Germany
dc.contributor.authoraffiliation[Esser, R.] Merck KGaA, Darmstadt, Germany
dc.contributor.authoraffiliation[Liu, E.] Merck KGaA, Darmstadt, Germany
dc.contributor.authoraffiliation[Adrian, S.] Merck KGaA, Darmstadt, Germany
dc.contributor.authoraffiliation[Lopez-Lopez, C.] Univ Hosp Marques de Valdecilla, IDIVAL, Santander, Spain
dc.contributor.funderMerck KGaA, Darmstadt, Germany
dc.date.accessioned2025-01-07T15:32:45Z
dc.date.available2025-01-07T15:32:45Z
dc.date.issued2021-07-03
dc.identifier.doi10.1016/j.annonc.2021.05.166
dc.identifier.essn1569-8041
dc.identifier.issn0923-7534
dc.identifier.unpaywallURLhttp://www.annalsofoncology.org/article/S0923753421013557/pdf
dc.identifier.urihttps://hdl.handle.net/10668/27224
dc.identifier.wosID670004200111
dc.issue.number3
dc.journal.titleAnnals of oncology
dc.journal.titleabbreviationAnn. oncol.
dc.language.isoen
dc.organizationSAS - Hospital Universitario Virgen del Rocío
dc.page.numberS136-S137
dc.publisherElsevier
dc.rights.accessRightsopen access
dc.titlePERSPECTIVE: Tepotinib plus cetuximab in patients with RAS/BRAF wild-type left-sided metastatic colorectal cancer and acquired resistance to anti-EGFR antibody therapy due to MET amplification
dc.typeconference output
dc.type.hasVersionVoR
dc.volume.number32
dc.wostypeMeeting Abstract

Files

Collections

SAS - Hospital Universitario Virgen del Rocío

© 2023 – Repositorio Institucional de Salud de Andalucía - Fundación Pública Andaluza Progreso y Salud - Consejería de Salud y Consumo de la Junta de Andalucía